Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0048514
Title: Identification of a Novel Calotropis procera Protein That Can Suppress Tumor Growth in Breast Cancer through the Suppression of NF-κB Pathway
Authors: Samy, R.P. 
Rajendran, P.
Li, F.
Anandi, N.M.
Stiles, B.G.
Ignacimuthu, S.
Sethi, G.
Chow, V.T.K.
Issue Date: 20-Dec-2012
Source: Samy, R.P., Rajendran, P., Li, F., Anandi, N.M., Stiles, B.G., Ignacimuthu, S., Sethi, G., Chow, V.T.K. (2012-12-20). Identification of a Novel Calotropis procera Protein That Can Suppress Tumor Growth in Breast Cancer through the Suppression of NF-κB Pathway. PLoS ONE 7 (12) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0048514
Abstract: Breast cancer is the most common cancer among women. To date, improvements in hormonal and cytotoxic therapies have not yet led to a sustained remission or cure. In the present study, we investigated the in vitro and in vivo antitumor activities of a novel Calotropis procera protein (CP-P) isolated from root bark. CP-P protein inhibited the proliferation and induced apoptosis of breast cancer cells through the suppression of nuclear factor kappaB (NF-kB) activation. CP-P, when administered individually or in combination with cyclophosphamide (CYC, 0.2 mg/kg) to rats with 7, 12-dimethyl benz(a)anthracene (DMBA)-induced breast cancer decreased tumor volume significantly without affecting the body weight. To elucidate the anticancer mechanism of CP-P, antioxidant activities such as superoxide dismutase (SOD), catalase (CAT), glutathione-s-transferase (GST) and non-enzymatic antioxidant - reduced glutathione (GSH), vitamin E and C generation in the breast were analyzed by various assays. SOD, CAT, GST, GSH, vitamin E and C levels were high in combination-treated groups (CP-P+CYC) versus the CYC alone-treated groups. Also, the combination was more effective in down-regulating the expression of NF-kB-regulated gene products (cyclin D1 and Bcl-2) in breast tumor tissues. Our findings indicate that CP-P possesses significant antitumor activity comparable to a commonly used anticancer drug, cyclophosphamide, and may form the basis of a novel therapy for breast cancer. © 2012 Samy et al.
Source Title: PLoS ONE
URI: http://scholarbank.nus.edu.sg/handle/10635/96862
ISSN: 19326203
DOI: 10.1371/journal.pone.0048514
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2012_Identification_of_a_Novel_Calotropis-published.PDF871.58 kBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

15
checked on Feb 7, 2018

WEB OF SCIENCETM
Citations

12
checked on Feb 7, 2018

Page view(s)

37
checked on Feb 20, 2018

Download(s)

4
checked on Feb 20, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.